Table 2.
Overview of non-biologic systemic treatments in pediatric psoriasis
Drug | Dosage | Side effects | Laboratory monitoring |
---|---|---|---|
Cyclosporine | 1.5 to 5 mg/kg/day | Renal toxicity, hypertension nausea, diarrhea, myalgias, headache, electrolyte abnormalities (hyperkalemia and hypomagnesemia), hyperlipidemia, hypertrichosis, and gingival hyperplasia | Blood count, creatinine, urea, cholesterol, triglycerides, electrolytes |
Fumaric acid esters | ≤720 mg/day | Gastrointestinal complaints, flushes, hematological abnormalities (lymphocytopenia and eosinophilia) | Blood count, liver enzymes |
Methotrexate | 0.2 to 0.7 mg/kg/week | Nausea, vomiting, fatigue, hematological abnormalities, hepatotoxicity, pulmonary toxicity | Blood count, liver enzymes |
Retinoids | ≤0.5 to 1 mg/kg/day |
Cheilitis, xerosis, epistaxis and increase of serum lipids and hepatic enzymes Skeletal abnormalities Teratogenicity |
Serum lipids and liver enzymes Radiographs of the spine |